Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Phase 1
86
about 1.6 years
12+
8 sites in CA, CO, IL +3
About this study
This trial is testing a treatment for atopic dermatitis. It compares ShA9 topical gel to placebo, and also looks at the safety of ShA9 when used with topical corticosteroids.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Clobetasol Ointment
- 2.Take Fluocinonide Ointment
- 3.Take Hydrocortisone Ointment
- +2 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
clobetasol, CARDIOVASCULAR SYSTEM, hydrocortisone
topical, injection (Injection)
Primary: Serious and non-serious treatment-emergent adverse events (TEAEs) related or possibly related to study treatment.
Secondary: Change in Pruritus Numeric Rating Scale (NRS) score., Serious and non-serious TEAEs related or possibly related to study treatment.
Dermatology